School of Medicine

Eric C. Leuthardt, M.D., a Washington University neurosurgeon at Barnes-Jewish Hospital, has been named one of this year’s Top Young Innovators by Technology Review, MIT’s Magazine of Innovation. The distinction is awarded each year to 100 individuals under age 35 whose innovative work in technology has a profound impact on the world.

More than 80 percent of hip fracture patients don’t fully recover with traditional rehabilitation methods. That’s why WUSM researchers are testing a new approach: combining extended exercise therapy with daily use of a topical testosterone gel. Elderly men and women with recent hip fractures may be eligible to participate.

Bob BostonMore than 140 people helped raise cancer awareness for the Siteman Cancer Center and broke a world record in the process.

A competitive horseback rider growing up, William C. Chapman, M.D., thought he wanted to be a veterinarian. But when it came time to decide between treating animals or humans, Chapman was swayed by some sage advice. “I was always frustrated by the notion that, for various reasons, veterinarians sometimes have to put an animal to […]

University researchers have found that a moderate exercise regimen is just as effective as a common blood pressure drug.

“One of our most talented clinicians and teachers,” says department head Alan L. Schwartz, he “serves as a role model, clinician and educator.”

Clinicians who treat AIDS patients may be able to use the HIV protease inhibitor ritonavir to reduce bone loss.

The bacterium responsible for strep throat and other disorders appears to use a single wasplike “stinger” to spread infection.

A biomedical engineer at WUSTL has determined love taps are better than love jolts in addressing defibrillation.When it comes to affairs of the heart, love taps are preferred over love jolts. That is the result of a team of heart researchers including Igor Efimov, Ph.D., associate professor of biomedical engineering at Washington University in St. Louis, trying to effect a better implantable heart defibrillator. Efimov and his colleagues have modeled a system where an implantable heart defibrillator focuses in on rogue electrical waves created during heart arrhythmia and busts up the disturbance, dissipating it and preventing cardiac arrest.

Ritonavir may slow bone loss in AIDS patients.In a collaborative study initiated by their clinical colleagues, scientists at the School of Medicine have shown that the AIDS drug ritonavir suppresses the creation and activity of cells that dismantle bone, potentially slowing bone loss and lowering the risk of osteoporosis in AIDS patients. The findings may encourage clinicians to consider permanently keeping ritonavir or a similar bone-sparing drug in the changing mixture of treatments for AIDS patients.